< Terug naar vorige pagina
Onderzoeker
Kelly Dufraing
- Disciplines:Laboratoriumgeneeskunde, Palliatieve zorg en zorg rond het levenseinde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Verpleegkunde, Andere paramedische wetenschappen, Andere translationele wetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Onderzoekseenheid Biomedische Kwaliteitszorg (Afdeling)
Lid
Vanaf18 jul 2016 → Heden
Projecten
1 - 1 of 1
- De beoordeling en verbetering van de kwaliteit van Europese testlaboratoria voor moleculaire oncologieVanaf18 jul 2016 → 22 dec 2022Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 10 van 15
- Quality in Molecular Oncology Testing Laboratories in Europe: a View from Different Angles(2022)
Auteurs: Kelly Dufraing, Els Dequeker
- Molecular pathology testing for non-small cell lung cancer: an observational study of elements currently present in request forms and result reports and the opinion of different stakeholders(2022)
Auteurs: Kelly Dufraing, Sara Vander Borght, Els Dequeker
- Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL(2020)
Auteurs: Kelly Dufraing, Els Dequeker
Pagina's: 553 - 565 - Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples(2020)
Auteurs: Cleo Keppens, Els Dequeker, Kelly Dufraing
Pagina's: 366 - 377 - Evolution of RAS testing over time: factors influencing mutation rates in metastatic colorectal cancer patients(2020)
Auteurs: Kelly Dufraing, Cleo Keppens, Sara Vander Borght, Els Dequeker
- External quality assessment for molecular diagnostic laboratories in Belgium: Can we improve it?(2020)
Auteurs: Kelly Dufraing, Els Dequeker
Pagina's: 39 - 49 - Two years of BRCA1 and BRCA2 somatic external quality assessment with Gen&Tiss scheme in France(2019)
Auteurs: Kelly Dufraing, Céline Garrec, Caroline Egele, Cleo Keppens, Jean Chiesa, Aude Lamy, Ludovic Lacroix, Alexandre Harlé, R Pascal, Kaat Van Casteren, et al.
- Variation in nomenclature of somatic variants for selection of oncological therapies: can we reach a consensus soon?(2019)
Auteurs: Cleo Keppens, Véronique Tack, Kelly Dufraing, Els Dequeker
Pagina's: 7 - 16 - Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study(2019)
Auteurs: Kelly Dufraing, Gert De Hertogh, Els Dequeker
Pagina's: 312 - 319 - Pre-Analytical Challenges during RAS Testing: Tissue Quality and the Estimation of Neoplastic Cell Percentage(2019)
Auteurs: Kelly Dufraing, Cleo Keppens, Bert Siebers, George Kafatos, Kimberly Lowe, Gaston Demonty, Els Dequeker, Han van Krieken
Pagina's: 1 - 1